https://www.selleckchem.com/products/n6f11.html
phy. Trial Registration Randomized clinical trial IRCT20180522039782N2; date of registration14/10/2018. Wilms tumor 1 associated protein (WTAP) modulates other genes via transcriptional and post-transcriptional regulation, in particular, by acting as a N6-methyladenosine writer or binding to the 3'UTR of mRNA, and promotes a variety of tumuors. However, the roles and mechanisms of WTAP in ovarian cancer are unknown. In this study, using univariate Cox analysis and online CPTA analysis, we found that WTAP was a poor prognostic factor for o
Like
Comment
Share
